• Takeda and Shattuck Labs partner to develop immunotherapies for cancer treatments pharmaceutical-technology
    August 15, 2017
    Takeda Pharmaceutical has entered a research collaboration with Shattuck Labs to study and develop checkpoint fusion proteins that have the potential to be used as highly differentiated, advanced immunotherapies for cancer.
  • Takeda, Shattuck Labs Announce Research Collaboration americanpharmaceuticalreview
    August 11, 2017
PharmaSources Customer Service